Sphingosine kinase: A promising cancer therapeutic target

Commentary to: Antitumor activity of Sphingosine Kinase 2 inhibitor ABC294640 and sorafenib in hepatocellular carcinoma xenografts Vladimir Beljanski, Clayton S. Lewis and Charles D. Smith

Saved in:
Bibliographic Details
Published in:Cancer biology & therapy 2011-04, Vol.11 (7), p.647-650
Main Authors: Antoon, James W., Beckman, Barbara S.
Format: Article
Language:English
Subjects:
Animals
Antineoplastic Agents - therapeutic use
Binding
Biology
Bioscience
Calcium
Cancer
Cell
Cycle
Enzyme Inhibitors - therapeutic use
Humans
Landes
Molecular Targeted Therapy
Neoplasms - drug therapy
Neoplasms - metabolism
Organogenesis
Phosphotransferases (Alcohol Group Acceptor) - metabolism
Proteins
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Commentary to: Antitumor activity of Sphingosine Kinase 2 inhibitor ABC294640 and sorafenib in hepatocellular carcinoma xenografts Vladimir Beljanski, Clayton S. Lewis and Charles D. Smith
ISSN:1538-4047
1555-8576
DOI:10.4161/cbt.11.7.14921